BIOMERICA INC. - COMM
0.3740
08-11月-24 12:20:04
15 分の遅延
株式
-0.0048
-1.27%
本日の幅
0.3530 - 0.4011
ISIN
N/A
ソース
NASDAQ
-
Diagnostics Industry Leader Jack Kenny Joins Biomerica’s Board of Directors
28 8 2023 08:19:00 提供 Nasdaq GlobeNewswire
-
Biomerica Reports Fiscal 2023 Year End Results
25 8 2023 17:00:00 提供 Nasdaq GlobeNewswire
-
03 8 2023 08:19:00 提供 Nasdaq GlobeNewswire
-
inFoods® IBS Test Now Validated for Use with Simple Finger Stick Whole Blood Collection Technology
18 5 2023 08:19:00 提供 Nasdaq GlobeNewswire
-
17 4 2023 07:47:00 提供 Nasdaq GlobeNewswire
-
Biomerica Reports Q3 Fiscal 2023 Results
14 4 2023 16:48:29 提供 Nasdaq GlobeNewswire
-
08 3 2023 08:19:00 提供 Nasdaq GlobeNewswire
-
Biomerica Announces Closing of $8 Million Underwritten Public Offering of Common Stock
07 3 2023 16:39:57 提供 Nasdaq GlobeNewswire
-
Biomerica Announces Pricing of $8 Million Underwritten Public Offering of Common Stock
03 3 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
Biomerica Announces Proposed Underwritten Public Offering of Common Stock
02 3 2023 17:15:01 提供 Nasdaq GlobeNewswire
-
Biomerica Reports Financial Results for Fiscal 2023 Second Quarter Ended November 30, 2022
13 1 2023 18:39:00 提供 Nasdaq GlobeNewswire
-
10 1 2023 08:19:00 提供 Nasdaq GlobeNewswire
-
08 12 2022 08:19:00 提供 Nasdaq GlobeNewswire
-
02 11 2022 08:19:00 提供 Nasdaq GlobeNewswire
-
14 10 2022 09:18:00 提供 Nasdaq GlobeNewswire
-
Biomerica Reports 30% Increase in Revenues for Fiscal Q1 2023 vs. Fiscal Q1 2022
13 10 2022 16:50:00 提供 Nasdaq GlobeNewswire
-
29 9 2022 08:19:00 提供 Nasdaq GlobeNewswire
-
Biomerica Plans Launch of InFoods® IBS Test; Names Robert Carlson as Chief Commercial Officer
30 8 2022 08:19:00 提供 Nasdaq GlobeNewswire
-
Biomerica Reports Fiscal 2022 Year End Results
29 8 2022 16:41:00 提供 Nasdaq GlobeNewswire